We provide a clear phenotype-genotype correlation with in silico, in vitro, and in vivo evidence to support pathogenic variants in OGDH leading to a neurodevelopmental disease characterized by global developmental delay, movement disorder, and metabolic aberrations. This evidence concerns the gene OGDH and movement disorder.